Skip to content
← Full study record

NCT00112827 · MORE INFO

Limitations, agreements, and source contact

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma · Source last updated 2025-06-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
pfrankel@coh.org
organization
City of Hope
phone
626-218-5265
title
Paul Frankel, Ph.D.
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
pfrankel@coh.org
organization
City of Hope
phone
626-218-5265
title
Paul Frankel, Ph.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice